Large-Scale Study Details Devastating Patient Harms Associated with Blood Culture Contamination
Magnolia Medical Technologies shared a study detailing the clinical and financial impacts of blood culture contamination on patient safety.
Magnolia Medical Technologies shared a study detailing the clinical and financial impacts of blood culture contamination on patient safety.
Thermo Fisher Scientific announced innovative proteomics solutions and several co-marketing agreements to advance the quality of proteomics workflows.
Hardy Diagnostics has released its latest chromogenic media, HardyCHROM Group A Strep agar, for selective cultivation of clinical specimens.
The contract covers the T2Dx instrument as well as the T2Bacteria and T2Candida panels, which detect sepsis-causing bacterial and fungal pathogens directly from whole blood.
The SureSelect XT HS2 RNA Reagent Kit features a modular design for a simple and parallel approach for both RNA and DNA samples with clinical NGS.
The kit combines the Steripath Gen2 initial specimen diversion device with additional supplies required for the collection of blood culture samples that are virtually free of contamination.
AuriFind provides a simple growth test on agar medium to determine if a suspected microbial clone is Candida auris or not.